GlaxoSmithKline named Philip Hampton as its next chairman as the pharmaceuticals giant struggles to right itself amid a series of probes over alleged overseas bribery.
from WSJ.com: US Business http://ift.tt/1vhuJXk
via IFTTT
from WSJ.com: US Business http://ift.tt/1vhuJXk
via IFTTT
No comments:
Post a Comment